sotorasib,adagrasib
amgen,mirati
['oval', 'lcsm,(-blcsm)', 'rova', 'adagrasib', 'sotorasib', 'biomarker']
exciting phase 2 adagrasib data from &amp; cross-trial comparison with sotorasib. similar efficacy, perhaps higher aes with adagrasib, encouraging 33% intracranial orr among treated/stable cns mets. approval soon? biomarkers of response remain immature. #asco22 #lcsm 
Medical oncology fellow @MSKcancercenter, prior @oslerresidency @harvardmed @yale. Precision medicine, Miami sports enthusiast.